GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (STU:R5XA) » Definitions » Shiller PE Ratio

Talphera (STU:R5XA) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Talphera Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Talphera Shiller PE Ratio Historical Data

The historical data trend for Talphera's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Shiller PE Ratio Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Talphera's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talphera's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Talphera's Shiller PE Ratio falls into.



Talphera Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Talphera's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Talphera's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.147/131.7762*131.7762
=-0.147

Current CPI (Mar. 2024) = 131.7762.

Talphera Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.416 100.560 -5.787
201409 -2.018 100.428 -2.648
201412 -5.190 99.070 -6.903
201503 -4.990 99.621 -6.601
201506 -3.564 100.684 -4.665
201509 1.960 100.392 2.573
201512 -4.406 99.792 -5.818
201603 -4.490 100.470 -5.889
201606 -4.272 101.688 -5.536
201609 -4.455 101.861 -5.763
201612 -3.982 101.863 -5.151
201703 -6.358 102.862 -8.145
201706 -5.162 103.349 -6.582
201709 -4.698 104.136 -5.945
201712 -3.211 104.011 -4.068
201803 -3.731 105.290 -4.670
201806 -3.424 106.317 -4.244
201809 -3.599 106.507 -4.453
201812 -3.164 105.998 -3.933
201903 -3.009 107.251 -3.697
201906 -2.832 108.070 -3.453
201909 -2.906 108.329 -3.535
201912 -3.240 108.420 -3.938
202003 -3.620 108.902 -4.380
202006 -1.421 108.767 -1.722
202009 -1.698 109.815 -2.038
202012 -1.644 109.897 -1.971
202103 -1.344 111.754 -1.585
202106 -1.328 114.631 -1.527
202109 -1.190 115.734 -1.355
202112 -1.062 117.630 -1.190
202203 -1.081 121.301 -1.174
202206 8.117 125.017 8.556
202209 -0.949 125.227 -0.999
202212 -0.944 125.222 -0.993
202303 -0.700 127.348 -0.724
202306 -0.369 128.729 -0.378
202309 -0.075 129.860 -0.076
202312 -0.193 129.419 -0.197
202403 -0.147 131.776 -0.147

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Talphera  (STU:R5XA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Talphera Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Talphera's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Talphera (STU:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (STU:R5XA) Headlines

No Headlines